DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,071 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $615,880 | +0.1% | 2,465 | 0.0% | 0.27% | -2.5% |
Q1 2024 | $615,560 | +9.6% | 2,465 | -78.7% | 0.28% | -3.1% |
Q3 2023 | $561,591 | -21.4% | 11,546 | +288.0% | 0.29% | -18.6% |
Q2 2023 | $714,240 | -4.8% | 2,976 | 0.0% | 0.36% | -11.9% |
Q1 2023 | $750,071 | -6.6% | 2,976 | -1.7% | 0.40% | -14.1% |
Q4 2022 | $803,161 | +2.7% | 3,026 | 0.0% | 0.47% | -4.7% |
Q3 2022 | $782,000 | -0.5% | 3,026 | -2.4% | 0.49% | +21.5% |
Q2 2022 | $786,000 | -8.0% | 3,101 | -0.8% | 0.40% | +4.7% |
Q1 2022 | $854,000 | -14.5% | 3,126 | +3.0% | 0.39% | -1.5% |
Q4 2021 | $999,000 | +8.1% | 3,036 | 0.0% | 0.39% | -0.8% |
Q3 2021 | $924,000 | +9.2% | 3,036 | -3.6% | 0.40% | +5.3% |
Q2 2021 | $846,000 | +18.3% | 3,151 | -0.8% | 0.38% | +5.9% |
Q1 2021 | $715,000 | +8.5% | 3,176 | +7.1% | 0.36% | -3.0% |
Q4 2020 | $659,000 | +3.3% | 2,965 | 0.0% | 0.37% | -14.9% |
Q3 2020 | $638,000 | +19.7% | 2,965 | -1.7% | 0.43% | -19.8% |
Q2 2020 | $533,000 | +32.9% | 3,015 | +4.0% | 0.54% | +22.9% |
Q1 2020 | $401,000 | -9.9% | 2,900 | 0.0% | 0.44% | +10.9% |
Q4 2019 | $445,000 | +15.3% | 2,900 | +8.4% | 0.39% | +1.8% |
Q3 2019 | $386,000 | +1.0% | 2,675 | 0.0% | 0.39% | -4.0% |
Q2 2019 | $382,000 | +8.2% | 2,675 | 0.0% | 0.40% | +5.5% |
Q1 2019 | $353,000 | +22.1% | 2,675 | -4.5% | 0.38% | +6.1% |
Q4 2018 | $289,000 | – | 2,800 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |